News
Welcome to the Cipla Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...
In conclusion, several Nifty 50 stocks, including Cipla, Sun Pharma and Infosys, experienced declines in Wednesday's trading ...
Join us on the Cipla Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay in ...
The US government has long sought to shift pharmaceutical manufacturing back to domestic soil, citing both economic and ...
Mumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the current Good ...
Cipla has announced that the United States Food and Drug Administration (USFDA) has classified its recent inspection of the company's manufacturing facility in Bommasandra, Bengaluru as Voluntary ...
The Hyderabad-based company's consolidated net profit rose 26.7% to 5.45 billion rupees ($62 million) for the quarter ended ...
Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding ...
Biocon and Aurobindo Pharma are identified as facing significant EPS impacts within the generics and biosimilars domain.
As global demand for next-generation therapies on diabetes and weight loss surges, Indian pharmaceutical companies are ...
Broad cap indices saw higher selling pressure. The Nifty midcap 100 index was down 0.54 per cent and Nifty smallcap 100 index ...
LASCO Distributors reported a 15.3 per cent drop in net profit to $304 million for Q1 2025/26, with revenues dipping slightly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results